Critical illness presents a complex challenge for patient recovery, often accompanied by increased nutritional demands and susceptibility to infections. Ningbo Inno Pharmchem Co., Ltd. is focused on providing essential pharmaceutical raw materials that support patient well-being, and L-Alanyl-L-Glutamine stands out for its significant role in critical care settings.

Critically ill patients frequently require intensive nutritional support, often through parenteral nutrition (PN). Glutamine, a key amino acid, plays a vital role in gut barrier function, immune response, and cellular energy metabolism. However, free glutamine is poorly soluble and unstable under the conditions required for PN administration and sterilization. This is where the dipeptide L-Alanyl-L-Glutamine emerges as a superior solution.

Research has demonstrated that L-Alanyl-L-Glutamine supplementation in PN can lead to tangible benefits for patients in intensive care units (ICUs). Notably, studies suggest a reduction in infectious morbidity, such as nosocomial pneumonia and urinary tract infections. This improvement in infection rates is crucial for preventing complications and facilitating a smoother recovery process.

Beyond infection control, L-Alanyl-L-Glutamine has also been associated with improved glycemic control in critically ill patients. Maintaining stable blood glucose levels is a significant challenge in ICUs, impacting overall patient outcomes. The dipeptide's ability to enhance insulin sensitivity and reduce the need for insulin administration, as observed in some studies, highlights its multifaceted benefits.

At Ningbo Inno Pharmchem Co., Ltd., we are committed to supplying high-quality L-Alanyl-L-Glutamine raw powder, recognizing its importance as a pharmaceutical intermediate. We offer competitive pricing for L-Alanyl-L-Glutamine CAS 39537-23-0, ensuring that healthcare providers have access to this vital compound. Our goal is to support the medical community by providing reliable and effective nutritional components.

The evidence supporting the use of L-Alanyl-L-Glutamine in critical care is compelling. By addressing the limitations of free glutamine and offering enhanced physiological benefits, this dipeptide represents a significant advancement in supportive therapy for critically ill patients. Ningbo Inno Pharmchem Co., Ltd. is proud to be a supplier of this crucial ingredient, contributing to improved patient care and outcomes.